A Clinical Study of Curcuvail® in Patients With Non-alcoholic Fatty Liver Disease

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 8, 2021

Primary Completion Date

November 25, 2021

Study Completion Date

November 25, 2021

Conditions

Fatty Liver Without Mention of Alcohol

Interventions

DRUG

Test Product: Curcuvail® 250mg capsule (Curcuma longa Extractcontaining 35% Curcuminoids)

Curcuma longa Extract containing 35% Curcuminoids Dose: One capsule Frequency: Twice Daily Route of administration: Oral Duration of therapy: 60Days

DRUG

Placebo product

Placebo product Dose:One capsule Frequency: Twice Daily Route of administration: Oral Duration of therapy: 60Days

Trial Locations (1)

Cod Research Pvt Ltd, Ahmedabad

All Listed Sponsors

lead

COD Research Private Ltd

OTHER_GOV

NCT06256926 - A Clinical Study of Curcuvail® in Patients With Non-alcoholic Fatty Liver Disease | Biotech Hunter | Biotech Hunter